Clinical Application of Reprogrammed Cells

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Clinical Application of Reprogrammed Cells

The firs method to make human iPSC used a retroviral vector delivery system, carrying the risk of transgene reactivation and insertional mutagenesis. Since then many other groups have used the same methods to reprogram cells to pluripotency  among others. After that research efforts focused on searching different ways to induce pluripotency without suffering genetic changes in order to prevent transgenes from reactivating and avoiding the risk of genomic recombination or insertional mutagenesis


Citation: Requena J, Palomo ABA, Sal MF, Christodoulou J, Canals JM, et al. (2014) The Future Challenges for the Clinical Application of Reprogrammed Cells. Human Genet Embryol 4:120

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger